Dementia-friendly Community Training Using Virtual Reality Among College Nursing Students

From the Classroom to the Rural Community: Engaging Nursing College Students to Create a Dementia-friendly Community Using Virtual Reality and World café Teaching Strategies

This study aims to evaluate the effectiveness of a dementia course using virtual reality, world café teaching method and community practice on knowledge of dementia and dementia-friendly community, attitude toward dementia, and empathy toward people with dementia among nursing college students.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This two-group randomised controlled trial aims to evaluate the effectiveness of a dementia course using virtual reality on knowledge of dementia and dementia-friendly community, attitude toward dementia, and empathy toward people with dementia among nursing college students.

The interventional group will receive the dementia course consists of dementia virtual reality activity, intergenerational learning, world café teaching method and community practice.

The control group will only receive the dementia course with intergenerational learning, world café teaching method and community practice but no dementia virtual reality activity.

Both groups will be assessed for their dementia knowledge, attitudes, empathy and knowledge of dementia-friendly community at baseline, week 8, and week 18.

Study Type

Interventional

Enrollment (Anticipated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hualien City, Taiwan, 970
        • Recruiting
        • Tzu Chi University of Science and Technology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • college nursing students with age ranged from 19 to 40 years,
  • Taiwanese nationality,
  • Sophomore and above
  • provide informed consent to participate in the study.

Exclusion Criteria:

college nursing students who do not meet the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dementia course with VR
Dementia course with virtual reality consists of dementia virtual reality activity, intergenerational learning, world café teaching method and community practice
dementia virtual reality activity, intergenerational learning, world café teaching method and community practice
Active Comparator: Dementia course with no VR
Dementia course with no virtual reality consists of intergenerational learning, world café teaching method and community practice with no dementia virtual reality activity.
dementia course, intergenerational learning, world café teaching method and community practice

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dementia Knowledge Assessment Scale (DKAS)
Time Frame: baseline
score of knowledge about dementia (0~50) higher scores indicate more knowledge about dementia
baseline
Dementia Knowledge Assessment Scale (DKAS)
Time Frame: week 8
score of knowledge about dementia (0~50) higher scores indicate more knowledge about dementia
week 8
Dementia Knowledge Assessment Scale (DKAS)
Time Frame: week 18
score of knowledge about dementia (0~50) higher scores indicate more knowledge about dementia
week 18
Approaches to Dementia Questionnaire (ADQ)
Time Frame: baseline
score of attitude toward people with dementia (19~95) higher scores indicate more positive attitude towards dementia
baseline
Approaches to Dementia Questionnaire (ADQ)
Time Frame: week 8
score of attitude toward people with dementia (19~95) higher scores indicate more positive attitude towards dementia
week 8
Approaches to Dementia Questionnaire (ADQ)
Time Frame: week 18
score of attitude toward people with dementia (19~95) higher scores indicate more positive attitude towards dementia
week 18
Jefferson Scale of Empathy (JSE)
Time Frame: baseline
score of empathy (20~140) higher scores indicate more empathy for people with dementia
baseline
Jefferson Scale of Empathy (JSE)
Time Frame: week 8
score of empathy (20~140) higher scores indicate more empathy for people with dementia
week 8
Jefferson Scale of Empathy (JSE)
Time Frame: week 18
score of empathy (20~140) higher scores indicate more empathy for people with dementia
week 18

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dementia-friendly community questionnaire
Time Frame: baseline
score of knowledge on dementia-friendly community (0~20) higher scores indicate more knowledge about dementia-friendly community
baseline
Dementia-friendly community questionnaire
Time Frame: week 8
score of knowledge on dementia-friendly community (0~20) higher scores indicate more knowledge about dementia-friendly community
week 8
Dementia-friendly community questionnaire
Time Frame: week 18
score of knowledge on dementia-friendly community (0~20) higher scores indicate more knowledge about dementia-friendly community
week 18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2022

Primary Completion (Anticipated)

July 31, 2023

Study Completion (Anticipated)

July 31, 2023

Study Registration Dates

First Submitted

October 31, 2022

First Submitted That Met QC Criteria

October 31, 2022

First Posted (Actual)

November 3, 2022

Study Record Updates

Last Update Posted (Actual)

November 10, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Dementia course with VR

3
Subscribe